| Mr Tidjane Thiam
| Tidjane was the Chief Financial Officer from March 2008 until his appointment as Group Chief Executive in 2009. Tidjane spent the first part of his professional career with McKinsey & Company in Paris and New York, serving insurance companies and banks. He then spent a number of years in Africa where he was Chief Executive and later Chairman of the National Bureau for Technical Studies and Development in Cote d'Ivoire and a cabinet member as Secretary of Planning and Development. Tidjane returned to France to become a partner with McKinsey & Company and one of the leaders of their Financial Institutions practice before joining Aviva in 2002. He worked at Aviva until 2008, holding successively the positions of Group Strategy and Development Director, Managing Director of Aviva International, Group Executive Director and Chief Executive Officer, Europe. Tidjane was a non-executive director of Arkema in France until November 2009. He is a member of the Board of the Association of British Insurers (ABI) and he was appointed as Chairman in July 2012. He is a member of the Council of the Overseas Development Institute (ODI) in London, a member of the Africa Progress Panel chaired by Kofi Annan and a sponsor of Opportunity International. Tidjane is a member of the UK-ASEAN Business Council and of the Strategic Advisory Group on UK Trade and Investment. In January 2012, Tidjane was appointed to the Prime Minister's Business Advisory Group and has been a member of the European Financial Round Table (EFR) since January 2013. Tidjane was awarded the Legion d'Honneur by the French President in July 2011. |
| Mr David-Alexandre Gros
| David-Alexandre Gros has a B.A. from Darmouth College (1995), an M.D. from Johns Hopkins University School of Medicine (1999), and an M.B.A. from Harvard Business School (2002). He began his career in clinical research at the Department of Urology of the Johns Hopkins Hospital, from 1996 to 1999, and acquiring clinical experience as a Resident Physician at the University of Pennsylvania Health System from 1999 to 2000. He started his advisory career in 2002 at McKinsey & Company as an Associate, was promoted to Engagement Manager in 2004 and to Associate Principal in 2006. In late 2006, he was appointed Vice President at Merrill Lynch, serving healthcare clients on a wide range of strategic, corporate finance and merger & acquisition issues. In 2009, he joined Centerview Partners, in San Franciso, California, as an advisor to healthcare companies as a Principal and founding member of the Healthcare Investment Banking practice. David-Alexandre Gros joined Sanofi as Chief Strategy Officer in September 2011. |
| Ms Suet Fern Lee
| Ms Suet Fern Leeis Independent Director at Sanofi SA since May 2011. Other current directorships and appointments Director of Axa,Director of Macquarie International Infrastructure Fund Ltd (Bermuda) Director of National Heritage Board (Singapore) Director of Rickmers Trust Management Pte Ltd (Singapore) Director of Stamford Corporate Services Pte Ltd (Singapore)Chairman of the Board of directors of the Asian Civilisations Museum (Singapore). Education and business experience, Law degree from Cambridge University (1980) Admitted to London (1981) and Singapore (1982) Bars Senior Partner of Stamford Law Corporation(Singapore). Since 2008 President of the Inter-Pacific Bar Association (Singapore)Since 2006 Member of the Board of trustees of Nanyang Technological University (Singapore)Since 2006 Member of the Accountant Advisory Board of the National University of Singapore Business School (Singapour) Since 2007 Member of the Advisory Committee of the Singapore Management University School of Law (Singapour). |
| Mr Elias Zerhouni
| Born in Algeria where he completed his initial medical training, Dr. Zerhouni continued his academic career at the Johns Hopkins University and Hospital (United States) in 1975 where he rose to the rank of professor of Radiology and Biomedical engineering. He served as Chair of the Russell H. Morgan Department of Radiology and Radiological Sciences, Vice Dean for Research and Executive Vice Dean of the School of Medicine from 1996 to 2002 before his appointment as Director of the National Institutes of Health of the United States of America from 2002 to 2008. Dr. Zerhouni was received as member of the U.S. National Academy of Sciences' Institute of Medicine in 2000. He was appointed as Chair of Innovation at the College de France, elected member of the French Academy of Medicine in 2010 and received the Transatlantic Innovation Leadership award in December 2011. He is the author of over 200 scientific publications and 8 patents. In February 2009, Sanofi named Dr. Zerhouni Scientific Advisor to the Chief Executive Officer and to the Senior Vice-President Research & Development. He was appointed President Global Research & Development and has served on the Executive Committee of Sanofi, since January 2011. He has just been received as member of the U.S. National Academy of Engineering. Dr. Zerhouni is a citizen of the United States of America, he also served on Danaher’s Board of Directors since 2009. |
| Ms Carole Piwnica
| Ms Carole Piwnica is Independent Director at Sanofi SA. She also serves as Chief executive officer of Naxos UK Ltd (United Kingdom), Director and Chairman of the Committee of Governance, Compensation and Appointment of Eutelsat Communications, Director of Louis Delhaize (Belgium) and Amyris Inc. (United States), Director, Chairman of the Corporate Responsibility Committee and member of the Compensation Committee of Aviva Plc (United Kingdom). Education and business experience - Degree in law, Université Libre de Bruxelles, Masters in law, New York University, Admitted to Paris and New York Bars, 1985-1991 - Attorney at Proskauer, Rose (NY) and Shearman & Sterling (Paris) with practice in mergers and acquisitions, 1991-1994 - General Counsel of Gardini & Associés, 1994-2000 Chief Executive Officer of Amylum France, then Chairman of Amylum Group. Past directorships held since 2006 - Director of Dairy Crest Plc (United Kingdom, 2007-2010), Vice-Chairman and Director of Tate & Lyle Plc (United Kingdom, 1996-2006) and Vice-Chairman for Governmental Affairs (2000-2006), Director of the CIAA (Confederation of the Food and Drink Industries of the European Union) (1996-2006), Director of Toepfel GmbH (Germany, 1996-2010) and of Spadel (Belgium, 1998-2004), Member of the Ethical Committee of Monsanto (United States, 2006-2009). Date of Birth - February 12, 1958. Nationality - Belgian. |
| Mr Igor Landau
| Mr Igor Landau is Director at Sanofi SA and Chairman of the Supervisory Board of Adidas-Salomon (Germany), Director of HSBC France and INSEAD, Member of the Supervisory Board of Allianz AG (Germany). Education and business experience - Degree from the Ecole des Hautes Etudes Commerciales (HEC) and from INSEAD (Master of Business Administration), 1968-1970 - Chief Executive Officer of the German subsidiary of La Compagnie du Roneo (Frankfurt), 1971-1975 - Management consultant at McKinsey (Paris), 1975-2004 - Various positions at the Rhône-Poulenc group, including member of the Management Board of Aventis (1999-2002) and Chairman of the Management Board of Aventis (2002-2004), 2001-2005 - Director of Essilor, 2002-2005 - Director of Thomson (now called Technicolor). Past directorships held since 2006 - Member of the Supervisory Board of Dresdner Bank (Germany, 2003-2006). Date of Birth - July 13, 1944. Nationality - French. |
| Ms Karen Linehan
| Karen Linehan graduated from Georgetown University with Bachelor of Arts and Juris Doctorate degrees. Prior to practicing law, Ms. Linehan served on the congressional staff of the Speaker of the U.S. House of Representatives from September 1977 to August 1986. Until December 1990, she was an Associate in a mid-size law firm in New York. In January 1991, she joined Sanofi as Assistant General Counsel of its U.S. subsidiary. In July 1996, Ms. Linehan moved to Paris to work on international matters within the Group and she has held a number of positions within the Legal Department, most recently as Vice President - Deputy Head of Legal Operations. She was appointed to her current position in March 2007. |
| Ms Anne Lauvergeon
| Ms Anne Lauvergeon is a non-executive director of Total SA from 2000 until May 2015. Chief Mining Engineer and a graduate of the École Normale Supérieure with a doctorate in physical sciences, Ms. Lauvergeon held various positions in industry before becoming Deputy Chief of Staff in the Office of the President of the Republic in 1990. She joined Lazard Frères et Cie as Managing Partner in 1995. From 1997 to 1999, she was Executive Vice President and member of the Executive Committee of Alcatel, in charge of industrial partnerships and international affairs. Ms. Lauvergeon served as Chairperson of the Management Board of Areva from July 2001 to June 2011 and Chairperson and Chief Executive Officer of Areva NC (formerly Cogema) from June 1999 to June 2011. Ms Anne Lauvergeon is Baord Member at Airbus Group SE. |
| Mr Michael Diekmann
| Michael Diekmann, Member; Chairman of the Board of Management of Allianz SE till may 2015; Companies at which Supervisory Board and similar positions were held: Allianz Deutschland AG; Allianz Global Investors AG; BASF AG; Dresdner Bank AG; Linde AG; Allianz S.p.A.; Allianz France S.A.; Assurances Generales de France. |
| Mr Ulf M. Schneider
| DR Ulf M. Schneider is a director at E I du Pont de Nemours and Co since October 22, 2014. He has been Chairman of the Supervisory Board of Management AG from April 15, 2005. He was a member of the Fresenius Medical Care AG Supervisory Board from May 2004 and Chairman of its Supervisory Board until the effective date of the transformation when he resigned upon the Company's transformation to a KGaA. He was Chief Financial Officer of FMC-AG from November 2001 until May 2003. On March 7, 2003, Dr Schneider announced his resignation from the FMC-AG Management Board to become Chairman of the Management Board of Fresenius AG (now Fresenius SE), effective May 28, 2003. Previously he was Group Finance Director for Gehe UK plc., a pharmaceutical wholesale and retail distributor, in Coventry, United Kingdom. He has held several senior executive and financial positions since 1989 with Gehe's majority shareholder, Franz Haniel & Cie. GmbH, Duisburg, a diversified German multinational company. Dr Schneider is Chairman of the Supervisory Board of Fresenius Kabi AG, HELIOS Kliniken GmbH, Eufets AG and Fresenius Medical Care Groupe France S.A.S., France. He is member of the Supervisory Board of Fresenius Kabi Austria GmbH, Austria, Fresenius Kabi Espana S.A., Spain and Fresenius HemoCare Nederlands B.V., Netherlands. Dr Schneider is member of the Board of Directors of FHC (Holdings), Ltd., Great Britain and of APP Pharmaceuticals, Inc., USA. Furthermore, Dr Schneider is Chairman of the Board of Directors of Fresenius Kabi Pharmaceuticals Holding, Inc., USA. |
| Ms Ana Botín
| Ana P. Botin, Born in 1960. Former executive vice president of Banco Santander, S.A., former chief executive officer of Banco Santander de Negocios from 1994 to 1999 and former executive chairwoman of Banesto from 2002 to 2010. She is Independent Director at Coca-Cola Co since 2013. In November 2010, she was appointed chief executive officer of Santander UK. She is also a member of the International Advisory Board of the New York Stock Exchange and of the board of Georgetown University. |
| Mr Peter Brabeck-Letmathe
| Peter Brabeck-Letmathe has been Vice-Chairman of the Board since 2008, a function he also held from 2000 to 2005. He has been a member of the Board since 1997 and a member of the Chairman’s and Governance Committee since 2008. He served on the Compensation Committee from 2008 until 2011. He also served from 2000 to 2005 on the Compensation Committee and from 2003 to 2005 on the Chairman’s and Governance Committee. Mr. Brabeck-Letmathe studied economics at the University of World Trade in Vienna. After graduating in 1968, he joined Nestlé SA’s sales operations in Austria. His career at Nestlé SA includes a variety of assignments in several European countries as well as in Latin America. Since 1987, he has been based at Nestlé SA’s headquarters in Vevey. Mr. Brabeck-Letmathe has been the Chairman of the Board of Directors of Nestlé SA since 2005. From 1997 to 2008, he was also the CEO of Nestlé SA. Mr. Brabeck-Letmathe has been a member of the Boards of Directors of L’Oréal SA, Paris, since 1997, and Exxon Mobil Corporation and Delta Topco (Formula 1), both since 2010. He is also a member of the Foundation Board of the World Economic Forum and a member of the European Round Table of Industrialists. |
| Mr John A. Lederer
| Mr John A. Lederer is a director at Walgreens Boots Alliance Inc since April 08, 2015. currently he serves as Chairman of the Board and Chief Executive Officer of Duane Reade, a privately held chain of retail pharmacies located primarily in the New York City area, a position that he accepted in April 2008. Prior to his current position, Mr Lederer served as President of Loblaw Companies Limited, Canada’s largest food distributor, from 2001 through September 2006. Mr Lederer also served as a director of Loblaw Companies Limited for much of this period, capping a 30-year career with Loblaw and its subsidiary companies during which he held a number of senior leadership positions. In these roles, he was responsible for the operation, performance, innovation and growth of national and regional banners, businesses and divisions. Mr Lederer is a former director of the Food Marketing Institute and is the founder and former Chair of the President’s Choice Children’s Charity. He holds a Bachelor of Arts degree from York University. Mr Lederer has served as a member of the Board of Directors of the Tim Horton Children’s Foundation since May of 2008. |
| Mr Daniel Dickinson
| DANIEL M. DICKINSON, 51, is currently Managing Partner of HCI Equity Partners (private equity investment). Other current directorships: Mistras Group, Inc. and HCI Equity Partners. Other directorships within the last five years: Progressive Waste Solutions Ltd. Mr. Dickinson has been a director of the Company since 2006. |
| Mr Richard Auchinleck
| Mr. Auchinleck began his service as a director of Conoco Inc. in 2001 prior to its merger with Phillips Petroleum Company in 2002. He served as President and Chief Executive Officer of Gulf Canada Resources Limited from 1998 until its acquisition by Conoco in 2001. Prior to his service as CEO, he was Chief Operating Officer of Gulf Canada from 1997 to 1998 and Chief Executive Officer for Gulf Indonesia Resources Limited from 1997 to 1998. Mr. Auchinleck currently serves on the boards of Enbridge Commercial Trust and Telus Corporation and previously served on the board of Red Mile Entertainment Inc. from 2005 to 2008. |
| Mr Wulf von Schimmelmann
| Wulf von Schimmelmann, Chief Executive Officer of Deutsche Postbank AG, a Germany-based financial services provider, from 1999 to June 2007. Before that, Mr. von Schimmelmann was a member of the Board of Managing Directors at BHF-Bank in Frankfurt am Main, where he was responsible for investment banking, payment transactions, and corporate customers. Mr. von Schimmelmann is Chair of the Supervisory Board of Deutsche Post AG, a member of the Supervisory Board of Maxingvest AG, and a director of Accenture Ltd. and Thomson Reuters International. Mr. von Schimmelmann served as Chair of the Supervisory Board of BAWAG P.S.K. from 2007 to 2009, and as a member of the Supervisory Board of Deutsche Telekom AG from 2006 to 2009. Mr. von Schimmelmann’s term expires in 2013. |
| Mr James C. Smith
| President and Chief Executive Officer of Thomson Reuters Corporation, the world's leading source of intelligent information for businesses and professionals, since January 2012 and its Chief Operating Officer from September 2011 to December 2011 and its Chief Executive Officer, Thomson Reuters Professional Division, from 2008 to 2011. Prior to the acquisition of Reuters Group PLC (Reuters) by The Thomson Corporation (Thomson) in 2008, he served as Chief Operating Officer of Thomson and as President and Chief Executive Officer of Thomson Learning's Academic and Reference Group. He began his career as a journalist and rose through the ranks at the Thomson Newspaper Group, which he joined in 1987, to become the head of its North America operations. With the sale of the Thomson Newspaper Group in 2000, he joined Thomson as Executive Vice President in 2001. Currently, he is a member of the International Business Council of the World Economic Forum, the International Advisory Boards of British American Business and the Atlantic Council. Pfizer Inc Director since 2014. Member of our Compensation Committee, our Regulatory and Compliance Committee, and our Science and Technology Committee. |
| Michael Parrett
| Michael S. Parrett (age 60). Michael S. Parrett was elected to the Board on May 7, 2009. Mr. Parrett has been an independent consultant since 2002. During 2002, 2003 and the first quarter of 2004 Mr. Parrett served as a financial consultant to Stillwater Mining Company. From 1990 to 2001 he was Chief Financial Officer and President of Rio Algom and Chief Executive of Billiton Base Metals. From 1983 to 1989 Mr. Parrett performed various financial functions, including Controller, Chief Financial Officer, Treasurer, Controller Marketing and Director Internal Audit at Falconbridge Limited. He was on the Board of Directors of Gabriel Resources Ltd from 2003 through 2010 and was Chairman from December 2005 through June 2010. He is currently on the Board of Directors of Pengrowth Corporation since 2004. Mr. Parrett was appointed to the Board of Directors of Sunshine Silver Mines Corporation and Mongolia Minerals Corporation in 2011. Mr. Parrett is a Chartered Accountant and received his Bachelor of Arts from York University. |
| Ms Linda B. Bammann
| Linda B. Bammann was Deputy Head of Risk Management at JPMorgan Chase from July 2004 until her retirement in 2005. Previously she was Executive Vice President and Chief Risk Management Officer at Bank One Corporation ("Bank One") from May 2001 to July 2004, and, before then, Senior Managing Director of Banc One Capital Markets, Inc. She was also a member of Bank One's executive planning group. From 1992 to 2000 she was a Managing Director with UBS Warburg LLC and predecessor firms. Ms. Bammann served as a Director of The Federal Home Mortgage Corporation ("Freddie Mac") from 2008 until 2013, during which time she was a member of its Compensation Committee. She also served as a member of Freddie Mac's Audit Committee from 2008 until 2010 and as Chair of its Business and Risk Committee from 2010 until 2013. Ms. Bammann also served as a Director of Manulife Financial Corporation from 2009 until 2012. Ms. Bammann was formerly a Board member of the Risk Management Association and Chair of the Loan Syndications and Trading Association. Ms. Bammann graduated from Stanford University and received an M.A. degree in Public Policy from the University of Michigan, USA. |
| Mr Michael M. Kanovsky
| Mr Michael M. Kanovsky is a member of board of directors in at Devon Energy Corp since 1998. Mr Kanovsky is a professional engineer and President of Sky Energy Corporation. Mr Kanovsky was a founder of both Northstar Energy Corporation and Bonavista Energy Corporation. From 1982 to 1998 he served on the Board of Directors of the Canadian-based Northstar Energy Corporation, which was acquired by Devon in 1998. Mr Kanovsky holds a Bachelor’s degree in Mechanical Engineering from Queen’s University as well as a Master’s degree in Business Administration from the Richard Ivey School of Business at the University of Western Ontario. Mr Kanovsky serves as a director of ARC Resources Ltd., Bonavista Petroleum Ltd., Pure Technologies Ltd. and TransAlta Corporation. |
